• Phone: +1-631-791-1145
  • Email: sales@imarcgroup.com

US Generic Injectables Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2019-2024

Generic injectables are widely used in the treatment of various chronic diseases such as cancer, diabetes, cardiovascular diseases, respiratory diseases, rheumatoid arthritis, osteoarthritis, osteoporosis, etc. In the United States, these drugs form an important part of the public healthcare system and contribute in significant savings for the patients and healthcare providers. According to IMARC Group’s new report titled “US Generic Injectables Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2019-2024”, the US generic injectables market reached a value of US$ 11.7 Billion in 2018, exhibiting a CAGR of more than 10% during 2011-2018. The market growth can be attributed to the low cost of these drugs as compared to their branded counterparts. Moreover, as there is limited price erosion and low competition in the market, the profit margins are significantly higher than commoditised generics.

Over the next few years, the market is expected to be driven by a number of favourable factors. The cases of chronic diseases have been increasing on account of ageing population, sedentary lifestyles and poor eating habits. This has resulted in a heightened demand for generic injectables. Furthermore, the drug shortages in the country coupled with speedy approvals by the USFDA are expected to boost the manufacturing of these drugs. Additionally, the patent expiry of a large number of branded injectable drugs is expected to support the market growth. As a result, the market is projected to reach a value of US$ 18.3 Billion by 2024, growing at a CAGR of around 7.5% during 2019-2024.

The report has segmented the market on the basis of therapeutic area and covers oncology, anaesthesia, anti-infectives, parenteral nutrition, cardiovascular diseases, etc. Among these, oncology generic injectables represent the largest segment. The report has further analysed the various containers used for generic injectables including vials, premix, prefilled syringes and ampoules. On the basis of distribution channels, the report finds that hospitals dominate the market, accounting for the majority of the share. The report has also examined the competitive landscape of the market and provides the profiles of the key players operative in it. Some the major players are Hospira, Hikma, App, Sagent, Sandoz and Henry Shein, Inc.

This report provides a deep insight into the US generic injectables industry covering all its essential aspects. This ranges from a macro overview of the market to micro details of the industry performance, recent trends, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc. The report also provides a comprehensive analysis for setting up a generic injectables manufacturing plant. The study analyses the processing and manufacturing requirements, project cost, project funding, project economics, expected returns on investment, profit margins, etc. This report is a must-read for entrepreneurs, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the US generic injectables industry in any manner.

Key Questions Answered in This Report:

  • How has the US generic injectables market performed so far and how will it perform in the coming years?
  • What are the price trends of generic injectables in the US?
  • What are the various stages in the value chain of the generic injectables industry?
  • What are the key driving factors and challenges in the US generic injectables industry?
  • What is the structure of the US generic injectables industry and who are the key players?
  • What is the degree of competition in the US generic injectables industry?
  • What are the profit margins in the generic injectables industry?
  • What are the key requirements for setting up a generic injectables manufacturing plant?
  • How are generic injectables manufactured?
  • What are the various unit operations involved in a generic injectables manufacturing plant?
  • What is the total size of land required for setting up a generic injectables manufacturing plant?
  • What are the machinery requirements for setting up a generic injectables manufacturing plant?
  • What are the raw material requirements for setting up a generic injectables manufacturing plant?
  • What are the packaging requirements for generic injectables?
  • What are the transportation requirements for generic injectables?
  • What are the utility requirements for setting up a generic injectables manufacturing plant?
  • What are the manpower requirements for setting up a generic injectables manufacturing plant?
  • What are the infrastructure costs for setting up a generic injectables manufacturing plant?
  • What are the capital costs for setting up a generic injectables manufacturing plant?
  • What are the operating costs for setting up a generic injectables manufacturing plant?
  • What will be the income and expenditures for a generic injectables manufacturing plant?
  • What is the time required to break-even?

1   Preface
2   Scope and Methodology

    2.1     Objectives of the study
    2.2     Stakeholders
    2.3     Data Sources
        2.3.1     Primary Sources
        2.3.2     Secondary Sources
    2.4     Market Estimation
        2.4.1     Bottom-Up Approach
        2.4.2     Top-Down Approach
    2.5     Forecasting Methodology
3   Executive Summary
4   Introduction

    4.1 Overview
    4.2 Key Industry Trends
5   Global Generic Drug Industry
    5.1 Market Overview
    5.2 Market Performance
        5.2.1 Sales Volume 
        5.2.2 Sales Value 
    5.3 Market Breakup by Country 
    5.4 Market Forecast
6   US Generic Drug Industry
    6.1 Market Overview
    6.2 Market Performance
        6.2.1 Sales Volume 
        6.2.2 Sales Value 
    6.3 Market Forecast
7   US Generic Drug Industry – Drug Delivery Systems
    7.1 Orals
    7.2 Injectables
    7.3 Dermal/Topical
    7.4 Inhalers
8   Global Generic Injectables Industry
    8.1 Market Overview
    8.2 Market Performance
    8.3 Market Breakup by Region 
    8.4 Market Breakup by Therapeutic Area
    8.5 Market Breakup by Containers
    8.6 Market Breakup by Distribution Channel
    8.7 Market Share of Key Players
    8.8 Market Forecast
9   US Generic Injectables Industry
    9.1 Market Overview
    9.2 Market Performance
    9.3 Market by Therapeutic Area
    9.4 Market by Containers
    9.5 Market by Distribution Channel
    9.6 Market Share of Key Players
    9.7 Market Forecast
    9.8 SWOT Analysis
        9.8.1 Overview
        9.8.2 Strength
        9.8.3 Weakness
        9.8.4 Opportunity
        9.8.5 Threat
    9.9 Value Chain Analysis
    9.10 Porters Five Forces Analysis
        9.10.1 Overview
        9.10.2 Bargaining Power of Buyers
        9.10.3 Bargaining Power of Suppliers
        9.10.4 Degree of Rivalry
        9.10.5 Threat of New Entrants
        9.10.6 Threat of Substitutes
     9.11    Key Success and Risk Factors
10   US Generic Injectable Market: Breakup by Therapeutic Area
     10.1 Oncology
        10.1.1 Market Trends
        10.1.2 Market Forecast
     10.2 Anaesthesia
        10.2.1 Market Trends
        10.2.2 Market Forecast
     10.3 Anti-infectives
        10.3.1 Market Trends
        10.3.2 Market Forecast
     10.4 Parenteral Nutrition
        10.4.1 Market Trends
        10.4.2 Market Forecast
     10.5 Cardiovascular
        10.5.1 Market Trends
        10.5.2 Market Forecast
11   US Generic Injectable Market: Breakup by Containers
     11.1 Vials
        11.1.1 Market Trends
        11.1.2 Market Forecast
     11.2 Ampoules
        11.2.1 Market Trends
        11.2.2 Market Forecast
     11.3 Premix
        11.3.1 Market Trends
        11.3.2 Market Forecast
     11.4 Prefilled Syringes
        11.4.1 Market Trends
        11.4.2 Market Forecast
12   US Generic Injectable Market: Breakup by Distribution Channel
     12.1 Hospitals
        12.1.1 Market Trends
        12.1.2 Market Forecast
     12.2 Retail Pharmacy 
        12.2.1 Market Trends
        12.2.2 Market Forecast
13   US Generic Injectable Market: Competitive Landscape
     13.1 Competitive Structure
     13.2 Market Breakup by Key Players
14   Generic Injectables Manufacturing Process
     14.1 Product Overview
     14.2 Detailed Process Flow
     14.3 Various Types of Unit Operations Involved
     14.4 Mass Balance and Raw Material Requirements
15   Project Details, Requirements and Costs Involved
     15.1 Land, Location and Site Development
     15.2 Construction Requirements 
     15.3 Machinery Requirements
     15.4 Machinery Pictures
     15.5 Raw Materials Requirements 
     15.6 Raw Material and Final Product Pictures
     15.7 Packaging Requirements 
     15.8 Transportation Requirements 
     15.9 Product Pricing and Margins Across Various Levels of the Supply Chain
16   Key Players Profiles 


List of Figures

Figure 1: Global: Generic Drug Market: Sales Volume Trends (in Billion Standard Units), 2011-2018
Figure 2: Global: Generic Drug Market: Sales Value Trends (in Billion US$), 2011-2018
Figure 3: Global: Generic Drug Market: Sales Value Breakup by Country (in %), 2018
Figure 4: Global: Generic Drug Market: Sales Volume Breakup by Country (in %), 2018
Figure 5: Global: Generic Drug Market Forecast: Sales Volume Trends (in Billion Standard Units), 2019-2024
Figure 6: Global: Generic Drug Market Forecast: Sales Value Trends (in Billion US$), 2019-2024
Figure 7: US: Generic Drug Market: Sales Volume Trends (in Billion Standard Units), 2011-2018
Figure 8: US: Generic Drug Market: Sales Value Trends (in Billion US$), 2011-2018
Figure 9: US: Generic Drug Market Forecast: Sales Volume Trends (in Billion Standard Units), 2019-2024
Figure 10: US: Generic Drug Market Forecast: Sales Value Trends (in Billion US$), 2019-2024
Figure 11: Global: Generic Drug Market: Drug Delivery System (in %), 2018
Figure 12: Global: Generic Injectables Market: Sales Value Trends (in Billion US$), 2011-2018
Figure 13: Global: Generic Injectables Market: Breakup by Region (in %), 2018
Figure 14: Global: Generic Injectables Market: Breakup by Therapeutic Area (in %), 2018
Figure 15: Global: Generic Injectables Market: Breakup by Containers (in %), 2018
Figure 16: Global: Generic Injectables Market: Breakup by Distribution Channels (in %), 2018
Figure 17: Global: Generic Injectables Market: Share of Key Players (in %), 2017
Figure 18: Global: Generic Injectables Market Forecast: Sales Value Trends (in Billion US$), 2019-2024
Figure 19: US: Generic Injectables Market: Sales Value Trends (in Billion US$), 2011-2018
Figure 20: US: Generic Injectables Market: Breakup by Therapeutic Area (in %), 2018
Figure 21: US: Generic Injectables Market: Breakup by Container (in %), 2018
Figure 22: US: Generic Injectables Market: Breakup by Distribution Channels (in %), 2018
Figure 23: US: Generic Injectables Market: Breakup by Key Players (in %), 2017
Figure 24: US: Generic Injectables Market Forecast: Sales Value Trends (in Billion US$), 2019-2024
Figure 25: US: Generic Injectables Industry: SWOT Analysis
Figure 26: US: Generic Injectables Industry: Value Chain Analysis
Figure 27: US: Generic Injectables Industry: Porter’s Five Forces Analysis
Figure 28: US: Generic Injectable (Oncology) Market: Value Trends (in Million US$), 2011 & 2018
Figure 29: US: Generic Injectable (Oncology) Market Forecast: Value Trends (in Million US$), 2019-2024
Figure 30: US: Generic Injectable (Anaesthesia) Market: Value Trends (in Million US$), 2011 & 2018
Figure 31: US: Generic Injectable (Anaesthesia) Market Forecast: Value Trends (in Million US$), 2019-2024
Figure 32: US: Generic Injectable (Anti-infectives) Market: Value Trends (in Million US$), 2011 & 2018
Figure 33: US: Generic Injectable (Anti-infectives) Market Forecast: Value Trends (in Million US$), 2019-2024
Figure 34: US: Generic Injectable (Parenteral Nutrition) Market: Value Trends (in Million US$), 2011 & 2018
Figure 35: US: Generic Injectable (Parenteral Nutrition) Market Forecast: Value Trends (in Million US$), 2019-2024
Figure 36: US: Generic Injectable (Cardiovascular) Market: Value Trends (in Million US$), 2011 & 2018
Figure 37: US: Generic Injectable (Cardiovascular) Market Forecast: Value Trends (in Million US$), 2019-2024
Figure 38: US: Generic Injectable (Vials) Market: Value Trends (in Million US$), 2011 & 2018
Figure 39: US: Generic Injectable (Vials) Market Forecast: Value Trends (in Million US$), 2019-2024
Figure 40: US: Generic Injectable (Ampoules) Market: Value Trends (in Million US$), 2011 & 2018
Figure 41: US: Generic Injectable (Ampoules) Market Forecast: Value Trends (in Million US$), 2019-2024
Figure 42: US: Generic Injectable (Premix) Market: Value Trends (in Million US$), 2011 & 2018
Figure 43: US: Generic Injectable (Premix) Market Forecast: Value Trends (in Million US$), 2019-2024
Figure 44: US: Generic Injectable (Prefilled Syringes) Market: Value Trends (in Million US$), 2011 & 2018
Figure 45: US: Generic Injectable (Prefilled Syringes) Market Forecast: Value Trends (in Million US$), 2019-2024
Figure 46: US: Generic Injectable Market: Sales through Hospitals (in Million US$), 2011 & 2018
Figure 47: US: Generic Injectable Market Forecast: Sales through Hospitals (in Million US$), 2019-2024
Figure 48: US: Generic Injectable Market: Sales through Retail Pharmacy (in Million US$), 2011 & 2018
Figure 49: US: Generic Injectable Market Forecast: Sales through Retail Pharmacy (in Million US$), 2019-2024
Figure 50: Generic Injectable Manufacturing: Detailed Process Flow
Figure 51: Generic Injectable Manufacturing Process: Conversion Rate of Feedstock
Figure 52: Generic Injectable Manufacturing: Production Cost Breakup (in %)
Figure 53: Generic Injectable Manufacturing: Profit Margins at Various Levels of the Supply Chain 


List of Tables

Table 1: Global: Generic Drug Market: Key Industry Highlights, 2018 and 2024
Table 2: US: Generic Drug Market: Key Industry Highlights, 2018 and 2024
Table 3: Global: Generic Injectables Market: Key Industry Highlights, 2018 and 2024
Table 4: US: Generic Injectables Market: Key Industry Highlights, 2018 and 2024
Table 5: US: Generic Injectables Market Forecast: Breakup by Therapeutic Area (in Million US$), 2019-2024
Table 6: US: Generic Injectables Market Forecast: Breakup by Containers (in Million US$), 2019-2024
Table 7: US: Generic Injectables Market Forecast: Breakup by Distribution Channel (in Million US$), 2019-2024
Table 8: US: Generic Injectables Market: Competitive Structure
Table 9: US: Generic Injectables Market: Key Players
Table 10: Generic Injectable Manufacturing Plant: Costs Related to Land and Site Development 
Table 11: Generic Injectable Manufacturing Plant: Costs Related to Civil Works 
Table 12: Generic Injectable Manufacturing Plant: Costs Related to Machinery Unit 
Table 13: Generic Injectable Manufacturing Plant: Raw Material Requirements
Table 14: US: Generic Injectables Market: Competitive Structure
Table 15: US: Generic Injectables Market: Key Players

Note: We value your privacy and will never rent or sell your email address. Privacy policy

Purchase Options




$ 1799

REACH OUT TO US

Call us on

( US: +1-631-791-1145 )
( UK: +44-702-409-7331 )
( India: +91-120-433-0800 )


Drop us an email at

sales@imarcgroup.com

Social Links